Trial Profile
A Randomized, Two-way Crossover Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets (Containing Contramid) (Administered Once Daily) and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily) at Steady State.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Sep 2011
Price :
$35
*
At a glance
- Drugs Trazodone (Primary)
- Indications Anxiety disorders; Depression
- Focus Pharmacokinetics
- Sponsors Altus Formulation Inc
- 14 May 2010 New trial record